Literature DB >> 10461533

Clinical courses and prognoses of pulmonary sarcoidosis.

S Nagai1, M Shigematsu, K Hamada, T Izumi.   

Abstract

In this article, long-term prognoses and prognostic factors of patients with sarcoidosis are reviewed. In patients with intrathoracic sarcoidosis, functional impairments and parenchymal lesions at the time of initial examination strongly predicted an unfavorable prognosis. We also discussed the significance of extrathoracic lesions in terms of clinical outcomes of intrathoracic sarcoidosis. In addition, we focused on the genetic approach and the new insights being offering with respect to the disease susceptibility and the development of pulmonary lesions.

Entities:  

Mesh:

Year:  1999        PMID: 10461533     DOI: 10.1097/00063198-199909000-00005

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  11 in total

Review 1.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

2.  Outcome of pulmonary sarcoidosis: a population-based study 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eva M Carmona; Eric L Matteson
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Early prediction of sarcoidosis prognosis with HLA typing: a 5 year follow-up study.

Authors:  Ezgi Ozyilmaz; Ozlem Goruroglu Ozturk; Ali Durmaz; Orhan Othman Hasan; Bugra Guzelbaba; Gulsah Seydaoglu; Sedat Kuleci; Ismail Hanta; Eren Erken; Ali Kocabas
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

4.  Association of HLA-DRB1 with Sarcoidosis Susceptibility and Progression in African Americans.

Authors:  Albert M Levin; Indra Adrianto; Indrani Datta; Michael C Iannuzzi; Sheri Trudeau; Jia Li; Wonder P Drake; Courtney G Montgomery; Benjamin A Rybicki
Journal:  Am J Respir Cell Mol Biol       Date:  2015-08       Impact factor: 6.914

5.  Serum vascular endothelial growth factor as a possible prognostic indicator in sarcoidosis.

Authors:  M Sekiya; A Ohwada; K Miura; S Takahashi; Y Fukuchi
Journal:  Lung       Date:  2003       Impact factor: 2.584

Review 6.  The role of exosomes from BALF in lung disease.

Authors:  Ziyu Liu; Jiaqing Yan; Lingling Tong; Shouyue Liu; Ying Zhang
Journal:  J Cell Physiol       Date:  2021-08-13       Impact factor: 6.513

Review 7.  Role of Bronchoscopic Techniques in the Diagnosis of Thoracic Sarcoidosis.

Authors:  Cecília Pedro; Natália Melo; Hélder Novais E Bastos; Adriana Magalhães; Gabriela Fernandes; Natália Martins; António Morais; Patrícia Caetano Mota
Journal:  J Clin Med       Date:  2019-08-28       Impact factor: 4.241

Review 8.  Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis.

Authors:  Patompong Ungprasert; Jay H Ryu; Eric L Matteson
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-08-02

Review 9.  Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review.

Authors:  Maria Giovanna Trivieri; Paolo Spagnolo; David Birnie; Peter Liu; Wonder Drake; Jason C Kovacic; Robert Baughman; Zahi A Fayad; Marc A Judson
Journal:  J Am Coll Cardiol       Date:  2020-10-20       Impact factor: 24.094

10.  Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan.

Authors:  Takeshi Hattori; Satoshi Konno; Noriharu Shijubo; Tetsuo Yamaguchi; Yukihiko Sugiyama; Sakae Honma; Naohiko Inase; Yoichi M Ito; Masaharu Nishimura
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.